top of page

PGIM India Small Cap Fund Review

Updated: Jul 17, 2021


PGIM India Mutual Fund has announced the launch of PGIM India Small cap fund. The scheme would be an open-ended scheme that will invests small cap companies stocks.

The NFO starting from 9th July 2021 and will end on 23rd July 2021. The fund will reopen for continuous sale and repurchase within 5 business days of allotment.


Investment Objective :

The investment objective of the scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of small cap companies.


However, there can be no assurance that the investment objective of the Scheme will be achieved. The Scheme does not guarantee/indicate any returns.


Benchmark: Nifty Small Cap 100 TRI


HOW WILL THE SCHEME ALLOCATE ITS ASSETS?

The asset allocation under the Scheme, under normal circumstances, will be as follows:

Fund Details:

New Fund Offer Period - NFO opens on: July 09, 2021, NFO closes on: July 23, 2021

New Fund Offer Price - The New Fund Offer price will be Rs. 10 /- per unit.

Minimum Amount for Application in the NFO - Rs. 5,000 and in multiples of Re. 1/- thereafter.


WHO MANAGES THE SCHEME?

Mr. Aniruddha Naha is the equity fund manager for the scheme. Mr. Kumaresh

Ramakrishnan is the debt fund manager for the scheme. Mr. Ravi Adukia will manage the overseas investments for the scheme.


Suitability: This scheme is suitable for investors who are seeking*

  • Capital appreciation over a long period of time.

  • Those who wish to invest in equity and equity related instruments of small cap companies.

  • Since it is a small cap scheme, and small caps are volatile, investors who have an investment tenure of 5 years or more should invest in this scheme


 
 

* Investors should consult their financial advisers if in doubt about whether the product is suitable for them.

Mutual Fund investments are subject to market risks, read all scheme related documents carefully. and Investors should consult their financial advisers if in doubt about whether the product is suitable for them.




Recent Posts

See All
bottom of page